deltatrials
Terminated NA INTERVENTIONAL 3-arm NCT02138578

Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

A Phase II Randomized Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for the Treatment of Localized Renal Cell Carcinoma (RCC)

Sponsor: University of Michigan Rogel Cancer Center

Conditions Renal Cell Carcinoma
Interventions RFA SBRT
Updated 15 times since 2017 Last updated: Oct 11, 2017 Started: May 31, 2014 Primary completion: Dec 31, 2016 Completion: Feb 28, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to changes in scanning procedure, and infeasible biopsy and baseline imaging, the trial closed for poor accrual and inability to follow patients.

Other terminated trials from University of Michigan Rogel Cancer Center

See all terminations from University of Michigan Rogel Cancer Center

Other Renal Cell Carcinoma trials with similar outcome

Browse all Renal Cell Carcinoma trials

A NA clinical study on Renal Cell Carcinoma, this trial is terminated or withdrawn. The trial is conducted by University of Michigan Rogel Cancer Center and has accumulated 15 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Aug 2017 · 5 months · monthly snapshot~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshot~Dec 2017 – ~May 2018 · 5 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Nov 2020 · 21 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated NA

▶ Show 10 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated NA

  2. Nov 2020 — Jan 2021 [monthly]

    Terminated NA

  3. Feb 2019 — Nov 2020 [monthly]

    Terminated NA

  4. Jun 2018 — Feb 2019 [monthly]

    Terminated NA

  5. May 2018 — Jun 2018 [monthly]

    Terminated NA

  6. Dec 2017 — May 2018 [monthly]

    Terminated NA

  7. Aug 2017 — Dec 2017 [monthly]

    Terminated NA

  8. Mar 2017 — Aug 2017 [monthly]

    Terminated NA

    Status: Recruiting → Terminated · Phase: PHASE2 → NA

  9. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE2

  10. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Michigan Rogel Cancer Center
Data source: University of Michigan Rogel Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations